PNC Financial Services Group’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

PNC Financial Services Group’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000	Closed	-$120	–	4786
2023 Q3	$120	Hold	1,000	–	–	﹤0.01%	4557
2023 Q2	$160	Hold	1,000	–	–	﹤0.01%	4679
2023 Q1	$150	Hold	1,000	–	–	﹤0.01%	4621
2022 Q4	$220	Hold	1,000	–	–	﹤0.01%	4627
2022 Q3	$0	Hold	1,000	–	–	﹤0.01%	4640
2022 Q2	$1K	Hold	1,000	–	–	﹤0.01%	4392
2022 Q1	$1K	Hold	1,000	–	–	﹤0.01%	4409
2021 Q4	$2K	Hold	1,000	–	–	﹤0.01%	4199
2021 Q3	$7K	Buy	+1,000	New	+$5.39K	﹤0.01%	3854

Other funds holding PAVMZ

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PNC Financial Services Group's PAVMZ Position: Q4 2023 in Review

PNC Financial Services Group sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q4 2023, closing a stake of 1,000 shares — an estimated $120 sold.

PNC Financial Services Group first reported a position in PAVMZ in Q3 2021 and held it in 9 quarters. The position peaked at $7K in Q3 2021. 2 funds tracked by Wall St. Rank hold PAVMZ as of Q4 2023.

PNC Financial Services Group reported no remaining PAVmed Inc. Series Z Warrant position as of Q4 2023 after selling out during the quarter.
PNC Financial Services Group sold 1,000 PAVmed Inc. Series Z Warrant shares in Q4 2023, an estimated $120.
PNC Financial Services Group first reported a position in PAVmed Inc. Series Z Warrant in Q3 2021 and held it in 9 quarters.
PNC Financial Services Group's PAVmed Inc. Series Z Warrant position peaked at $7K in Q3 2021.
2 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q4 2023.

Based on PNC Financial Services Group's 13F filing for Q4 2023, filed 9 Feb 2024.